EpiAxis executives attend US biotech conferences

EpiAxis executives attend US biotech conferences

It's an exciting month for EpiAxis Therapeutics as we return to face-to-face biotech conferences after more than two years of virtual attendance. Chairman Dr David Fuller is currently representing EpiAxis at the ASCO 2022 Annual Meeting in Chicago; while CEO Dr Jeremy...

read more
EpiAxis Therapeutics presents at Bioshares Biotech Summit

EpiAxis Therapeutics presents at Bioshares Biotech Summit

EpiAxis Therapeutics was pleased to attend and present at the 16th Bioshares Biotech Summit this month in Albury, NSW. BioShares is a life science conference mainly targeting ASX-listed Australian biotech companies, biotech investors, fund managers and brokers and...

read more

 

Professor Sudha Rao